Sanja Jelača

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Pharmaceutics

Diseases (Basel, Switzerland)

University of Belgrade, Faculty of Biology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Belgrade, Faculty of Biology

Serbia

PHD :: Molecular Oncology

University of Belgrade, Faculty of Biology

Serbia

MSC :: Molecular Biology and Physiology

University of Belgrade, Faculty of Biology

Serbia

BSC :: Molecular Biology and Physiology

Publications

Marijana P Kasalović, Dušan S Dimić, Sanja Jelača, Danijela Maksimović-Ivanić, Sanja Mijatović, Bojana B Zmejkovski, Simon H F Schreiner, Tobias Rüffer, Nebojša Đ Pantelić, Goran N Kaluđerović
Trimethyltin(IV) Bearing 3-(4-Methyl-2-oxoquinolin-1(2H)-yl)propanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marijana P Kasalović, Dušan S Dimić, Sanja Jelača, Danijela Maksimović-Ivanić, Sanja Mijatović, Bojana B Zmejkovski, Simon H F Schreiner, Tobias Rüffer, Nebojša Đ Pantelić, Goran N Kaluđerović
Trimethyltin(IV) Bearing 3-(4-Methyl-2-oxoquinolin-1(2H)-yl)propanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Sanja Jelača, Ivan P Jovanovic, Dijana Bovan, Sladjana Pavlovic, Nevena Gajovic, Duško Dunđerović, Zora Dajić-Stevanović, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Antimelanoma Effects of Alchemilla vulgaris : A Comprehensive In Vitro and In Vivo Study. Diseases (Basel, Switzerland) 12 (6) (2024)
Marijana P Kasalović, Sanja Jelača, Žiko Milanović, Danijela Maksimović-Ivanić, Sanja Mijatović, Jelena Lađarević, Bojan Božić, Zoran S Marković, Duško M Dundjerović, Tobias Rüffer, Robert Kretschmer, Goran N Kaluđerović, Nebojša Đ Pantelić
Novel triphenyltin(IV) compounds with carboxylato N -functionalized 2-quinolones as promising potential anticancer drug candidates: in vitro and in vivo evaluation. Dalton transactions (Cambridge, England : 2003) (2024)
Sanja Jelača, Ivan P Jovanovic, Dijana Bovan, Sladjana Pavlovic, Nevena Gajovic, Duško Dunđerović, Zora Dajić-Stevanović, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Antimelanoma Effects of Alchemilla vulgaris : A Comprehensive In Vitro and In Vivo Study. Diseases (Basel, Switzerland) 12 (6) (2024)
Marijana P Kasalović, Sanja Jelača, Žiko Milanović, Danijela Maksimović-Ivanić, Sanja Mijatović, Jelena Lađarević, Bojan Božić, Zoran S Marković, Duško M Dundjerović, Tobias Rüffer, Robert Kretschmer, Goran N Kaluđerović, Nebojša Đ Pantelić
Novel triphenyltin(IV) compounds with carboxylato N -functionalized 2-quinolones as promising potential anticancer drug candidates: in vitro and in vivo evaluation. Dalton transactions (Cambridge, England : 2003) 53 (19) (2024)
Sanja Jelača, Ivan P Jovanovic, Dijana Bovan, Marina Z Jovanovic, Milena M Jurisevic, Duško M Dundjerović, Zora Dajic-Stevanovic, Nebojsa Arsenijevic, Sanja Mijatović, Danijela Maksimović-Ivanić
Dual Role of Alchemilla vulgaris L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marijana P Kasalović, Dušan S Dimić, Sanja Jelača, Danijela Maksimović-Ivanić, Sanja Mijatović, Bojana B Zmejkovski, Simon H F Schreiner, Tobias Rüffer, Nebojša Đ Pantelić, Goran N Kaluđerović
Trimethyltin(IV) Bearing 3-(4-Methyl-2-oxoquinolin-1(2H)-yl)propanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Sanja Jelača, Ivan P Jovanovic, Dijana Bovan, Sladjana Pavlovic, Nevena Gajovic, Duško Dunđerović, Zora Dajić-Stevanović, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Antimelanoma Effects of Alchemilla vulgaris : A Comprehensive In Vitro and In Vivo Study. Diseases (Basel, Switzerland) 12 (6) (2024)
Sanja Jelača, Ivan P Jovanovic, Dijana Bovan, Marina Z Jovanovic, Milena M Jurisevic, Duško M Dundjerović, Zora Dajic-Stevanovic, Nebojsa Arsenijevic, Sanja Mijatović, Danijela Maksimović-Ivanić
Dual Role of Alchemilla vulgaris L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Sanja Jelača, Ivan P Jovanovic, Dijana Bovan, Marina Z Jovanovic, Milena M Jurisevic, Duško M Dundjerović, Zora Dajic-Stevanovic, Nebojsa Arsenijevic, Sanja Mijatović, Danijela Maksimović-Ivanić
Dual Role of Alchemilla vulgaris L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 15 (2) (2023)
Milica B Markelic, Marija Mojic, Dijana Bovan, Sanja Jelača, Zorana Jović, Milica Purić, Djuro Koruga, Sanja Mijatović, Danijela Maksimović-Ivanić
Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo . Nanomaterials (Basel, Switzerland) 13 (3) (2023)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy. RSC medicinal chemistry 14 (12) (2023)
Milica B Markelic, Marija Mojic, Dijana Bovan, Sanja Jelača, Zorana Jović, Milica Purić, Djuro Koruga, Sanja Mijatović, Danijela Maksimović-Ivanić
Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo . Nanomaterials (Basel, Switzerland) 13 (3) (2023)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15 , 682. Pharmaceutics 15 (6) (2023)
Sebastian Braun, Sanja Jelača, Markus Laube, Sven George, Bettina Hofmann, Peter Lönnecke, Dieter Steinhilber, Jens Pietzsch, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Synthesis and In Vitro Biological Evaluation of p -Carborane-Based Di- tert -butylphenol Analogs. Molecules (Basel, Switzerland) 28 (11) (2023)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 15 (2) (2023)
Milica B Markelic, Marija Mojic, Dijana Bovan, Sanja Jelača, Zorana Jović, Milica Purić, Djuro Koruga, Sanja Mijatović, Danijela Maksimović-Ivanić
Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo . Nanomaterials (Basel, Switzerland) 13 (3) (2023)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15 , 682. Pharmaceutics 15 (6) (2023)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 15 (2) (2023)
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy. RSC medicinal chemistry 14 (12) (2023)
Sanja Jelača, Zora Dajić-Stevanović, Nenad L Vukovic, Stefan Kolašinac, Antoaneta Trendafilova, Paraskev T Nedialkov, Miroslava Stanković, Nasta Tanić, Nikola T Tanić, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Beyond Traditional Use of Alchemilla vulgaris : Genoprotective and Antitumor Activity In Vitro. Molecules (Basel, Switzerland) 27 (23) (2022)
Sanja Jelača, Zora Dajić-Stevanović, Nenad L Vukovic, Stefan Kolašinac, Antoaneta Trendafilova, Paraskev T Nedialkov, Miroslava Stanković, Nasta Tanić, Nikola T Tanić, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Beyond Traditional Use of Alchemilla vulgaris : Genoprotective and Antitumor Activity In Vitro. Molecules (Basel, Switzerland) 27 (23) (2022)
Sanja Jelača, Zora Dajić-Stevanović, Nenad L Vukovic, Stefan Kolašinac, Antoaneta Trendafilova, Paraskev T Nedialkov, Miroslava Stanković, Nasta Tanić, Nikola T Tanić, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Beyond Traditional Use of Alchemilla vulgaris : Genoprotective and Antitumor Activity In Vitro. Molecules (Basel, Switzerland) 27 (23) (2022)
Sanja Jelača, Zora Dajić-Stevanović, Nenad L Vukovic, Stefan Kolašinac, Antoaneta Trendafilova, Paraskev T Nedialkov, Miroslava Stanković, Nasta Tanić, Nikola T Tanić, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Beyond Traditional Use of Alchemilla vulgaris : Genoprotective and Antitumor Activity In Vitro. Molecules (Basel, Switzerland) 27 (23) (2022)
Sanja Jelača, Zora Dajić-Stevanović, Nenad L Vukovic, Stefan Kolašinac, Antoaneta Trendafilova, Paraskev T Nedialkov, Miroslava Stanković, Nasta Tanić, Nikola T Tanić, Aleksandar Acovic, Sanja Mijatović, Danijela Maksimović-Ivanić
Beyond Traditional Use of Alchemilla vulgaris : Genoprotective and Antitumor Activity In Vitro. Molecules (Basel, Switzerland) 27 (23) (2022)
Benedikt Schwarze, Sanja Jelača, Linda Welcke, Danijela Maksimović-Ivanić, Sanja Mijatovic, Evamarie Hey-Hawkins
2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes. ChemMedChem 14 (24) (2019)

Sanja Jelača.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sanja Jelača